ROYAL BANK OF CANADA - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$46,000
+35.3%
4,161
+60.9%
0.00%
Q2 2023$34,000
+88.9%
2,586
+94.3%
0.00%
Q1 2023$18,000
-66.0%
1,331
-50.7%
0.00%
Q4 2022$53,000
+960.0%
2,700
+785.2%
0.00%
Q3 2022$5,000
+25.0%
305
+80.5%
0.00%
Q2 2022$4,000
-90.0%
169
-86.4%
0.00%
Q1 2022$40,000
-74.7%
1,246
-63.5%
0.00%
Q4 2021$158,000
+167.8%
3,412
+57.7%
0.00%
Q3 2021$59,000
-6.3%
2,164
-12.5%
0.00%
Q2 2021$63,000
+6.8%
2,474
+42.8%
0.00%
Q1 2021$59,000
+555.6%
1,732
+532.1%
0.00%
Q4 2020$9,0002740.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders